Arrowhead Research | ARWR - Loan Capital

Stock Price
65.85
Daily Change
1.21 1.86%
Monthly
0.24%
Yearly
225.32%
Q1 Forecast
67.19

Arrowhead Research reported $538.1M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Alnylam Pharmaceuticals USD 1.04B 13.75M Sep/2025
Arrowhead Research USD 538.1M 323.22M Dec/2025
Incyte USD 35.37M 3.61M Sep/2025
Ionis Pharmaceuticals USD 28.78M 596.71M Sep/2025
Ligand Pharmaceuticals USD 445.49M 445.44M Sep/2025
Merck USD 39.97B 6B Sep/2025
Moderna USD 26M 6M Sep/2025
Novartis USD 24.24B 174M Sep/2025
Sarepta Therapeutics USD 1.04B 104.31M Sep/2025
TG Therapeutics USD 245.34M 303K Sep/2025
Ultragenyx Pharmaceutical USD 782.75M 11.3M Jun/2025
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025
Xencor USD 87.78M 6.96M Sep/2025